©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111627
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111627
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111627
Table 1 The baseline characteristics of the training and validation sets, n (%)
| Variable | Testing (n = 254) | Training (n = 596) | P value |
| ENTPD6 | 5.26 (0.66) | 5.23 (0.90) | 0.705 |
| Gender | 0.481 | ||
| Female | 150 (59.1) | 369 (61.9) | |
| Male | 104 (40.9) | 227 (38.1) |
- Citation: Wang G, Liu T, Zhang JX, Li YR, Zhu WJ, Wang JL, Dong WW, Zhang YY, Li YM, Yang LX, He LX, He WT. Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6. World J Clin Oncol 2025; 16(11): 111627
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111627.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111627